273 related articles for article (PubMed ID: 30628063)
1. The histone demethylase UTX/KDM6A in cancer: Progress and puzzles.
Schulz WA; Lang A; Koch J; Greife A
Int J Cancer; 2019 Aug; 145(3):614-620. PubMed ID: 30628063
[TBL] [Abstract][Full Text] [Related]
2. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract][Full Text] [Related]
3. Contingencies of UTX/KDM6A Action in Urothelial Carcinoma.
Lang A; Yilmaz M; Hader C; Murday S; Kunz X; Wagner N; Wiek C; Petzsch P; Köhrer K; Koch J; Hoffmann MJ; Greife A; Schulz WA
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30987376
[TBL] [Abstract][Full Text] [Related]
4. Lysine Demethylase KDM6A in Differentiation, Development, and Cancer.
Tran N; Broun A; Ge K
Mol Cell Biol; 2020 Sep; 40(20):. PubMed ID: 32817139
[TBL] [Abstract][Full Text] [Related]
5. UTX Mutations in Human Cancer.
Wang L; Shilatifard A
Cancer Cell; 2019 Feb; 35(2):168-176. PubMed ID: 30753822
[TBL] [Abstract][Full Text] [Related]
6. Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma.
Yi J; Shi X; Xuan Z; Wu J
Cancer Lett; 2021 Feb; 499():188-200. PubMed ID: 33253789
[TBL] [Abstract][Full Text] [Related]
7. Catalytic domain-dependent and -independent transcriptional activities of the tumour suppressor histone H3K27 demethylase UTX/KDM6A in specific cancer types.
Sun W; Lee KL; Poellinger L; Masai H; Kato H
Epigenetics; 2023 Dec; 18(1):2222245. PubMed ID: 37300822
[TBL] [Abstract][Full Text] [Related]
8. Loss of UTX/KDM6A and the activation of FGFR3 converge to regulate differentiation gene-expression programs in bladder cancer.
Barrows D; Feng L; Carroll TS; Allis CD
Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25732-25741. PubMed ID: 32989154
[TBL] [Abstract][Full Text] [Related]
9. The H3K27me3 demethylase UTX in normal development and disease.
Van der Meulen J; Speleman F; Van Vlierberghe P
Epigenetics; 2014 May; 9(5):658-68. PubMed ID: 24561908
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of UTX/KDM6A Enriches Precursor Cell Populations in Urothelial Cell Cultures and Cell Lines.
Lang A; Whongsiri P; Yilmaz M; Lautwein T; Petzsch P; Greife A; Günes C; Köhrer K; Niegisch G; Hoffmann M; Schulz WA
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32326336
[TBL] [Abstract][Full Text] [Related]
11. UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition.
Ezponda T; Dupéré-Richer D; Will CM; Small EC; Varghese N; Patel T; Nabet B; Popovic R; Oyer J; Bulic M; Zheng Y; Huang X; Shah MY; Maji S; Riva A; Occhionorelli M; Tonon G; Kelleher N; Keats J; Licht JD
Cell Rep; 2017 Oct; 21(3):628-640. PubMed ID: 29045832
[TBL] [Abstract][Full Text] [Related]
12. Lysine demethylases KDM6A and UTY: The X and Y of histone demethylation.
Gažová I; Lengeling A; Summers KM
Mol Genet Metab; 2019 May; 127(1):31-44. PubMed ID: 31097364
[TBL] [Abstract][Full Text] [Related]
13. [Research Advances in Lysine-specific Demethylase 6A and Its Application in Treating Leukemia].
Shen J; Zeng ZH; Yang L; Zeng MJ; Ouyang ZS; Zhao MY; Yang MH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Aug; 41(4):548-555. PubMed ID: 31484620
[TBL] [Abstract][Full Text] [Related]
14. AZFa candidate gene
Vogt PH; Zimmer J; Bender U; Strowitzki T
Reprod Fertil; 2021 Apr; 2(2):151-160. PubMed ID: 35128450
[TBL] [Abstract][Full Text] [Related]
15. Histone demethylase UTX is a therapeutic target for diabetic kidney disease.
Chen H; Huang Y; Zhu X; Liu C; Yuan Y; Su H; Zhang C; Liu C; Xiong M; Qu Y; Yun P; Zheng L; Huang K
J Physiol; 2019 Mar; 597(6):1643-1660. PubMed ID: 30516825
[TBL] [Abstract][Full Text] [Related]
16. UTX demethylase activity is required for satellite cell-mediated muscle regeneration.
Faralli H; Wang C; Nakka K; Benyoucef A; Sebastian S; Zhuang L; Chu A; Palii CG; Liu C; Camellato B; Brand M; Ge K; Dilworth FJ
J Clin Invest; 2016 Apr; 126(4):1555-65. PubMed ID: 26999603
[TBL] [Abstract][Full Text] [Related]
17. UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease.
Rizq O; Mimura N; Oshima M; Momose S; Takayama N; Itokawa N; Koide S; Shibamiya A; Miyamoto-Nagai Y; Rizk M; Nakajima-Takagi Y; Aoyama K; Wang C; Saraya A; Ito R; Seimiya M; Watanabe M; Yamasaki S; Shibata T; Yamaguchi K; Furukawa Y; Chiba T; Sakaida E; Nakaseko C; Tamaru JI; Tai YT; Anderson KC; Honda H; Iwama A
Leukemia; 2023 Sep; 37(9):1895-1907. PubMed ID: 37198323
[TBL] [Abstract][Full Text] [Related]
18. Diverse ways to be specific: a novel Zn-binding domain confers substrate specificity to UTX/KDM6A histone H3 Lys 27 demethylase.
Kim E; Song JJ
Genes Dev; 2011 Nov; 25(21):2223-6. PubMed ID: 22056667
[TBL] [Abstract][Full Text] [Related]
19. [Distributions of H3K27me3 and its modification enzymes in different tissues of mice].
Wang Y; Wang X; Zhang R; Zhang Z; Wang Y; Yang B; Wang G; Zhang X; Ma F; Xu H; Wu X; Zhang F; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Nov; 33(11):1491-1497. PubMed ID: 29268852
[TBL] [Abstract][Full Text] [Related]
20. UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.
Benyoucef A; Palii CG; Wang C; Porter CJ; Chu A; Dai F; Tremblay V; Rakopoulos P; Singh K; Huang S; Pflumio F; Hébert J; Couture JF; Perkins TJ; Ge K; Dilworth FJ; Brand M
Genes Dev; 2016 Mar; 30(5):508-21. PubMed ID: 26944678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
